UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes

Health and quality of life outcomes, 2009-10, Vol.7 (1), p.91-91, Article 91

2009

Volltextzugriff (PDF)

Lifetime cost of ischemic stroke in germany : Results and national projections from a population-based stroke registry the erlangen stroke project

Stroke (1970), 2006-05, Vol.37 (5), p.1179-1183

2006

Volltextzugriff (PDF)

Prospective Study of Amphotericin B Formulations in Immunocompromised Patients in 4 European Countries

Clinical infectious diseases, 2006-08, Vol.43 (4), p.e29-e38

2006

Volltextzugriff (PDF)

Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins

European journal of preventive cardiology, 2012-02, Vol.19 (1), p.109-117

2012

Volltextzugriff (PDF)

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

European journal of medical research, 2012-04, Vol.17 (1), p.7-7, Article 7

2012

Volltextzugriff (PDF)

Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany

European journal of cancer (1990), 2007-01, Vol.43 (2), p.299-307

2007

Volltextzugriff (PDF)

Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value

Current medical research and opinion, 2012-08, Vol.28 (8), p.1281-1287

2012

Volltextzugriff (PDF)

Cost of clinical events in health economic evaluations in Germany: a systematic review

Cost effectiveness and resource allocation, 2012-05, Vol.10 (1), p.7-7

2012

Volltextzugriff (PDF)

Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany

The European journal of health economics, 2012-06, Vol.13 (3), p.365-374

2012

Volltextzugriff (PDF)

The Disparity in Access to New Medication by Type of Health Insurance: Lessons from Germany

Medical care, 2004-05, Vol.42 (5), p.487-491

2004

Volltextzugriff (PDF)

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study

Infection and drug resistance, 2013, Vol.6 (default), p.15-25

2013

Volltextzugriff (PDF)

Blood pressure control in the year following coronary events

International journal of cardiology, 2008-11, Vol.130 (2), p.205-210

2008

Volltextzugriff (PDF)

Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway

PharmacoEconomics, 2004-01, Vol.22 Suppl 3 (S3), p.49-61

2004

Volltextzugriff (PDF)

Regional variation in medication following coronary events in Germany

International journal of cardiology, 2005-06, Vol.102 (1), p.47-53

2005

Volltextzugriff (PDF)

Simvastatin initiated early after heart transplantation: 8-year prospective experience

Circulation (New York, N.Y.), 2003-01, Vol.107 (1), p.93-97

2003

Volltextzugriff (PDF)

Accessing a New Medication in Germany: A Novel Approach to Assess a Health Insurance-Related Barrier

Annals of epidemiology, 2005-11, Vol.15 (10), p.756-761

2005

Volltextzugriff (PDF)

Quantifying Delay in Access to New Medical Treatment: An Application of Risk Advancement Period Methodology

Epidemiology (Cambridge, Mass.), 2004-03, Vol.15 (2), p.202-207

2004

Volltextzugriff (PDF)

Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA1c value

Current medical research and opinion, 2012-08, Vol.28 (8), p.1281-1287

2012

Volltextzugriff (PDF)

Simvastatin after orthotopic heart transplantation. Costs and consequences

PharmacoEconomics, 1999-03, Vol.15 (3), p.279-289

1999

Volltextzugriff (PDF)

Berufliche Wiedereingliederung nach kardiologischer Rehabilitation

International journal of public health, 2003-12, Vol.48 (6), p.370-378

2003

Volltextzugriff (PDF)

Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA 1c value

Current medical research and opinion, 2012-08, Vol.28 (8), p.1281-1287

2012

Volltextzugriff (PDF)

Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors

European journal of cardiovascular prevention and rehabilitation, 2005-02, Vol.12 (1), p.37-45

2005

Volltextzugriff (PDF)

Real-World Effectiveness of Lipid-Lowering Therapy in Male and Female Outpatients with Coronary Heart Disease: Relation to Pre-Treatment Low-Density Lipoprotein-Cholesterol, Pre-Treatment Coronary Heart Disease Risk, and other Factors

European journal of cardiovascular prevention and rehabilitation, 2005-02, Vol.12 (1), p.37-45

2005

Volltextzugriff (PDF)

Outpatient costs of osteoporosis in a national health insurance population

Clinical therapeutics, 1999-11, Vol.21 (11), p.2001-2014

1999

Volltextzugriff (PDF)

Migraine Consultation Patterns in Primary Care. Results From the Pcaom Study 1994-96

Cephalalgia, 1999-11, Vol.19 (9), p.831-840

1999

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)
Dissertationen
(1)

Sprache

Englisch
(29)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes

Lifetime cost of ischemic stroke in germany : Results and national projections from a population-based stroke registry the erlangen stroke project

Prospective Study of Amphotericin B Formulations in Immunocompromised Patients in 4 European Countries

Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry

Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany

Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA(1c) value

Cost of clinical events in health economic evaluations in Germany: a systematic review

Cost-effectiveness of extended-release niacin/laropiprant added to a stable simvastatin dose in secondary prevention patients not at cholesterol goal in Germany

The Disparity in Access to New Medication by Type of Health Insurance: Lessons from Germany

Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study

Blood pressure control in the year following coronary events

Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway

Regional variation in medication following coronary events in Germany

Simvastatin initiated early after heart transplantation: 8-year prospective experience

Accessing a New Medication in Germany: A Novel Approach to Assess a Health Insurance-Related Barrier

Quantifying Delay in Access to New Medical Treatment: An Application of Risk Advancement Period Methodology

Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA1c value

Simvastatin after orthotopic heart transplantation. Costs and consequences

Berufliche Wiedereingliederung nach kardiologischer Rehabilitation

Lower risk of hypoglycemia with sitagliptin compared to glipizide when either is added to metformin therapy: a pre-specified analysis adjusting for the most recently measured HbA 1c value

Real-world effectiveness of lipid-lowering therapy in male and female outpatients with coronary heart disease: relation to pre-treatment low-density lipoprotein-cholesterol, pre-treatment coronary heart disease risk, and other factors

Real-World Effectiveness of Lipid-Lowering Therapy in Male and Female Outpatients with Coronary Heart Disease: Relation to Pre-Treatment Low-Density Lipoprotein-Cholesterol, Pre-Treatment Coronary Heart Disease Risk, and other Factors

Outpatient costs of osteoporosis in a national health insurance population

Migraine Consultation Patterns in Primary Care. Results From the Pcaom Study 1994-96

Suchergebnisse filtern